141 related articles for article (PubMed ID: 23390452)
1. Erlotinib induced trichomegaly of the eyelashes.
Jeon SH; Ryu JS; Choi GS; Kim JS; Kwon HY; Kim MS; Nam HS; Cho JH; Kwak SM; Lee HL; Kim HJ; Hong GJ
Tuberc Respir Dis (Seoul); 2013 Jan; 74(1):37-40. PubMed ID: 23390452
[TBL] [Abstract][Full Text] [Related]
2. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Celik T; Kosker M
Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
[TBL] [Abstract][Full Text] [Related]
3. Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.
Wang SB; Lei KJ; Liu JP; Jia YM
Oncol Lett; 2015 Aug; 10(2):954-956. PubMed ID: 26622603
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
Cohen PR; Escudier SM; Kurzrock R
Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
[TBL] [Abstract][Full Text] [Related]
5. Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.
Zheng H; Zhang H; Zhang T; Wang Q; Hu F; Li B
Exp Ther Med; 2016 Sep; 12(3):1287-1292. PubMed ID: 27588051
[TBL] [Abstract][Full Text] [Related]
6. Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.
Goel V; Raina S; Chandragouda D; Singh S; Talwar V; Patnaik N
Int J Trichology; 2014 Jan; 6(1):23-4. PubMed ID: 25114450
[TBL] [Abstract][Full Text] [Related]
7. Trichomegaly induced by erlotinib.
Papadopoulos R; Chasapi V; Bachariou A
Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
Saif MW; Gnanaraj J
Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
[TBL] [Abstract][Full Text] [Related]
9. Eyelash trichomegaly: review of congenital, acquired, and drug-associated etiologies for elongation of the eyelashes.
Paul LJ; Cohen PR; Kurzrock R
Int J Dermatol; 2012 Jun; 51(6):631-46; quiz 643-4, 646. PubMed ID: 22607279
[TBL] [Abstract][Full Text] [Related]
10. Persistent hair growth during treatment with the EGFR inhibitor erlotinib.
Alexandrescu DT; Kauffman CL; Dasanu CA
Dermatol Online J; 2009 Mar; 15(3):4. PubMed ID: 19379648
[TBL] [Abstract][Full Text] [Related]
11. Lady with Long Eyelashes…!
Inamadar SS; Kumar NSP
Int J Trichology; 2022; 14(2):71-72. PubMed ID: 35531491
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib-associated trichomegaly.
Lane K; Goldstein SM
Ophthalmic Plast Reconstr Surg; 2007; 23(1):65-6. PubMed ID: 17237698
[TBL] [Abstract][Full Text] [Related]
13. Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes.
Hutchison DM; Duffens A; Yale K; Park A; Cardenas K; Mesinkovska NA
J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):536-546. PubMed ID: 34919300
[TBL] [Abstract][Full Text] [Related]
14. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
[TBL] [Abstract][Full Text] [Related]
15. Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types.
Park S; Lee SY; Kim D; Sim YS; Ryu JS; Choi J; Lee SH; Ryu YJ; Lee JH; Chang JH
BMC Cancer; 2021 Jan; 21(1):52. PubMed ID: 33430803
[TBL] [Abstract][Full Text] [Related]
16. A case of acquired trichomegaly following treatment with erlotinib.
Jazayeri F; Malhotra R
BMJ Case Rep; 2009; 2009():. PubMed ID: 21687012
[TBL] [Abstract][Full Text] [Related]
17. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN
J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793
[No Abstract] [Full Text] [Related]
18. Eyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy.
Agrawal CR; Goyal P; Doval DC; Dutta K; Domadia K; Kothiwal S
Int J Trichology; 2018; 10(1):44-46. PubMed ID: 29440861
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan.
Chang CH; Lee CH; Ko JC; Chang LY; Lee MC; Wang JY; Yu CJ
Cancer Med; 2017 Jul; 6(7):1563-1572. PubMed ID: 28639751
[TBL] [Abstract][Full Text] [Related]
20. Trichomegaly secondary to erlotinib.
Desai RU; Rachakonda LP; Saffra NA
Can J Ophthalmol; 2009 Dec; 44(6):e65. PubMed ID: 20052001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
